PT Ekadharma International Tbk, (EKAD) Fair Value & Analysis
Basic Materials · ID · Market cap 594B IDR
Fair value as of: Jul 17, 2026
From 23 valuation models · updated 24 days ago
Fair value updated Jul 17, 2026, revised from 295.81 IDR to 270.06 IDR (−8.7%) since Jun 24, 2026. Share price +4.7% over the past month.
A solid business, screening 52% undervalued on our models.
What matters now
- The price is below even our cautious bear case (206.64 IDR). The market is more pessimistic than our downside scenario.
- Solid quality (63/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range 153.00 IDR – 273.71 IDR · fair‑value band 206.64 IDR – 333.47 IDR · the 178.00 IDR price screens below the 270.06 IDR fair value. Dashed = 300-day average. As of Jul 17, 2026.
Analysis
PT Ekadharma International Tbk, (EKAD) currently trades at 178.00 IDR, while our model-based Fair Value estimate is 270.06 IDR, implying the stock looks roughly 51.7% undervalued today. The Quality Score stands at 63/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, PT Ekadharma International Tbk, generated revenue of 543B IDR at a net margin of 9.2%. Revenue grew 10.7% year over year. It earns a return on equity of 4.0%. The balance sheet holds a net cash position of 57.3B IDR. Fundamentals as of Jul 17, 2026
Our scenario range runs from 206.64 IDR (bear case) to 333.47 IDR (bull case); at 178.00 IDR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 24% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at 52%, EKAD screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: DCF Models (353.20 IDR) versus Earnings-Based (164.99 IDR). Highest evidence: Growth DCF (80).
Notify me when EKAD reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 58
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Ekadharma International Tbk, together with its subsidiaries, engages in manufacturing and sale of self-adhesive tapes and related supplementary materials in Indonesia and Malaysia. It operates through Sticking Plaster and Others segments.
Full company description
PT Ekadharma International Tbk, together with its subsidiaries, engages in manufacturing and sale of self-adhesive tapes and related supplementary materials in Indonesia and Malaysia. It operates through Sticking Plaster and Others segments. The company offers lint roller, accessories, industrial tape, packaging products, and cutters; cloth tape/masking tape products; reflective, PVC electrical, and aluminum foil tape; cling wrap, and aluminum foil; kraft tape; OPP tape, including custom, printed, and OPP color tape; and air column bag products. It also engages in general trading business. The company sells its products under the Daimaru, SUPERFIX, and BESTPACK brands. The company was formerly known as PT Ekadharma Widya Grafika and changed its name to PT Ekadharma International Tbk in 2006. The company was founded in 1981 and is headquartered in Tangerang, Indonesia. PT Ekadharma International Tbk is a subsidiary of PT Ekadharma Inti Perkasa.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Ekadharma International Tbk, reported revenue of 530B IDR in FY2025 versus 630B IDR in FY2021, a compound −4.2%/yr. Reported net income was 53.0B IDR in FY2025, compounding −15.6%/yr from FY2021.
of which total revenue −0.3 pp · buybacks/dilution +0.0 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch EKAD: get an alert when its fair value changes →
Peer Group
Specialty Chemicals · 669 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $489.98 | $222.03 | -55% |
| Nan Ya Plastics Corporation 1303 | 181.50 TWD | 255.83 TWD | +41% |
| Wanhua Chemical Group 600309 | ¥70.04 | ¥68.03 | -3% |
| Novozymes A/S NSISB | kr 428.20 | kr 179.66 | -58% |
| Asian Paints Limited ASIANPAINT | ₹2,689 | ₹668.81 | -75% |
| Solar Industries India Limited SOLARINDS | ₹18,236 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,560 | ₹351.84 | -77% |
| PT Chandra Asri Pacific Tbk TPIA | 1,805 IDR | 2,888 IDR | +60% |
| Linde India Limited LINDEINDIA | ₹7,115 | ₹757.93 | -89% |
| Berger Paints India Limited BERGEPAINT | ₹493.70 | ₹164.29 | -67% |
Compare PT Ekadharma International Tbk, with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is PT Ekadharma International Tbk, (EKAD) overvalued or undervalued?
What is the fair value of EKAD?
What is the quality score of EKAD?
What is the revenue of PT Ekadharma International Tbk, (EKAD)?
What is the net profit margin of EKAD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Ekadharma International Tbk, and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.